Global Rare Disease Genetic Testing Market Size study, by Type (Neurological Disorders, Immunological Disorders, Hematology Diseases, Endocrine & Metabolism Diseases, Cancer, Musculoskeletal Disorders, Cardiovascular Disorders, Dermatology Diseases, Other Rare Diseases) Technology (Next Generation Sequencing, Array Technology, PCR - based Testing, FISH, Sanger Sequencing, Karyotyping) Specialty (Molecular Genetic Tests ,Chromosomal Genetic Tests ,Biochemical Genetic Tests) End-use (Research Laboratories & CROs, Hospitals & Clinics, Diagnostic Laboratories)and Regional Forecasts 2021-2027

BIZ4355334
200 Pages
May 2021
Medical Devices

Download Sample Get Discount

Global Rare Disease Genetic Testing Market is valued approximately USD 0.9186 Billion in 2020 and is anticipated to grow with a healthy growth rate of more than 10.9% over the forecast period 2021-2027. Rare Disease Genetic Testing is a test which presents the range of all the genes which are currently known to cause human disease. There are about 6000 genes which reported to be clinically relevant. These genes contains a select set of genes or gene region which are suspected to have relationship with certain diseases. This lead to a rise in the number of already present genes and as a result it further increased the market growth opportunity for this sector as it allows to collect sufficient amount of data which enables to continue clinical research for future discoveries. These diseases possess a threat to the mankind and needs to be diagnosed timely and accurately. This proves to be a driving factor for the market. The lack of awareness to these conditions is a primary challenge for the market. The Misdiagnosis of the diseases can result in interventions which could later be considered inappropriate for the underlying disorder. Therefore there is an urgent need to raise awareness about the aspects of these diseases like the challenges concerning with regard to diagnosis and clinical implementation of available diagnostic ways. Along with all the above stated factors technological advancements in collection of data and interpretation for clinical practice has also driven the market. Various efforts have been made by the market players in order to collect data from different ethnicities.

The regional analysis of global Rare Disease Genetic Testing Market is considered for the key regions such as Asia Pacific, North America, Europe, Latin America and Rest of the World. North America is the leader in Genetic Testing Market with an overall share of 47% of the total market in 2019.There will be a surge in the number of patients in the coming years this will further allow the market to grow. On the other hand, Asia Pacific is expected to grow more significantly in the coming years due to the increased awareness and rising populations in the Asian countries.

Major market player included in this report are:

Quest Diagnostics Inc.

Centogene N.V.

Invitae Corporation

3billion, Inc.

Arup Laboratories

Eurofins Scientific

Strand Life Sciences

Ambry Genetics

Perkin Elmer, Inc.

Macrogen, Inc.

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Type:Neurological Disorders

Immunological Disorders

Hematology Diseases

Endocrine & Metabolism Diseases

Cancer

Musculoskeletal Disorders

Cardiovascular Disorders

Dermatology Diseases

Other Rare Diseases

By Technology:Next Generation Sequencing

Array Technology

PCR - based Testing

FISH

Sanger Sequencing

Karyotyping

By Specialty:Molecular Genetic Tests

Chromosomal Genetic Tests

Biochemical Genetic Tests

By End-use:Research Laboratories & CROs

Hospitals & Clinics

Diagnostic Laboratories

By Region:

• North America

o U.S.

o Canada

• Europe

o UK

o Germany

o France

o Spain

o Italy

o ROE

• Asia Pacific

o China

o India

o Japan

o Australia

o South Korea

o RoAPAC

• Latin America

o Brazil

o Mexico

• Rest of the World

Furthermore, years considered for the study are as follows:

Historical year – 2018, 2019

Base year – 2020

Forecast period – 2021 to 2027

Target Audience of the Global Rare Disease Genetic Testing Market in Market Study:

Key Consulting Companies & Advisors

Large, medium-sized, and small enterprises

Venture capitalists

Value-Added Resellers (VARs)

Third-party knowledge providers

Investment bankers

Investors

Chapter 1.Executive Summary

1.1. Market Snapshot

1.2. Global & Segmental Market Estimates & Forecasts, 2019-2027 (USD Billion)

1.2.1. Rare Disease Generic Testing Market , by Region, 2019-2027 (USD Billion)

1.2.2. Rare Disease Generic Testing Market , by Disease Type, 2019-2027 (USD Billion)

1.2.3. Rare Disease Generic Testing Market , by Technology Outlook, 2019-2027 (USD Billion)

1.2.4. Rare Disease Generic Testing Market , by Speciality Outlook, 2019-2027 (USD Billion)

1.2.5. Rare Disease Generic Testing Market , by End use Outlook, 2019-2027 (USD Billion)

1.3. Key Trends

1.4. Estimation Methodology

1.5. Research Assumption

Chapter 2. Global Rare Disease Generic Testing Market Definition and Scope

2.1. Objective of the Study

2.2. Market Definition & Scope

2.2.1. Scope of the Study

2.2.2. Industry Evolution

2.3. Years Considered for the Study

2.4. Currency Conversion Rates

Chapter 3. Global Rare Disease Generic Testing Market Dynamics

3.1. Rare Disease Generic Testing Market Impact Analysis (2019-2027)

3.1.1. Market Drivers

3.1.1.1. The need for an accurate and timely diagnosis for rare conditions

3.1.2. Market Challenges

3.1.2.1. Lack of awareness about the diseases and its underlying effects

3.1.3. Market Opportunities

3.1.3.1. Technological advancements in data collection and interpretation for clinical practice

Chapter 4. Global Rare Disease Generic Testing Market Industry Analysis

4.1. Porter’s 5 Force Model

4.1.1. Bargaining Power of Suppliers

4.1.2. Bargaining Power of Buyers

4.1.3. Threat of New Entrants

4.1.4. Threat of Substitutes

4.1.5. Competitive Rivalry

4.1.6. Futuristic Approach to Porter’s 5 Force Model (2018-2027)

4.2. PEST Analysis

4.2.1. Political

4.2.2. Economical

4.2.3. Social

4.2.4. Technological

4.3. Investment Adoption Model

4.4. Analyst Recommendation & Conclusion

Chapter 5. Global Rare Disease Generic Testing Market , by Disease Type

5.1. Market Snapshot

5.2. Global Rare Disease Generic Testing Market by Disease Type, Performance - Potential Analysis

5.3. Global Rare Disease Generic Testing Market Estimates & Forecasts by Disease Type 2018-2027 (USD Billion)

5.4. Rare Disease Generic Testing Market , Sub Segment Analysis

5.4.1. Neurological Disorders,

5.4.2. Immunological Disorders,

5.4.3. Hematology Diseases,

5.4.4. Endocrine & Metabolism Diseases,

5.4.5. Cancer,

5.4.6. Musculoskeletal Disorders,

5.4.7. Cardiovascular Disorders,

5.4.8. Dermatology Diseases,

5.4.9. Other Rare Diseases

Chapter 6. Global Rare Disease Generic Testing Market , by Technology Outlook

6.1. Market Snapshot

6.2. Global Rare Disease Generic Testing Market by Technology Outlook, Performance - Potential Analysis

6.3. Global Rare Disease Generic Testing Market Estimates & Forecasts by Technology Outlook 2018-2027 (USD Billion)

6.4. Rare Disease Generic Testing Market , Sub Segment Analysis

6.4.1. Next Generation Sequencing

6.4.2. Array Technology

6.4.3. PCR - based Testing

6.4.4. FISH

6.4.5. Sanger Sequencing

6.4.6. Karyotyping

Chapter 7. Global Rare Disease Generic Testing Market , by Speciality Outlook

7.1. Market Snapshot

7.2. Global Rare Disease Generic Testing Market by Speciality Outlook, Performance - Potential Analysis

7.3. Global Rare Disease Generic Testing Market Estimates & Forecasts by Speciality Outlook 2018-2027 (USD Billion)

7.4. Rare Disease Generic Testing Market , Sub Segment Analysis

7.4.1. Molecular Genetic Tests

7.4.2. Chromosomal Genetic Tests

7.4.3. Biochemical Genetic Tests

Chapter 8. Global Rare Disease Generic Testing Market , by End use Outlook

8.1. Market Snapshot

8.2. Global Rare Disease Generic Testing Market by End use Outlook, Performance - Potential Analysis

8.3. Global Rare Disease Generic Testing Market Estimates & Forecasts by End use Outlook 2018-2027 (USD Billion)

8.4. Rare Disease Generic Testing Market , Sub Segment Analysis

8.4.1. Research Laboratories & CROs,

8.4.2. Hospitals & Clinics,

8.4.3. Diagnostic Laboratories

Chapter 9. Global Rare Disease Generic Testing Market , Regional Analysis

9.1. Rare Disease Generic Testing Market , Regional Market Snapshot

9.2. North America Rare Disease Generic Testing Market

9.2.1. U.S. Rare Disease Generic Testing Market

9.2.1.1. Disease Type breakdown estimates & forecasts, 2018-2027

9.2.1.2. Technology Outlook breakdown estimates & forecasts, 2018-2027

9.2.1.3. Speciality Outlook breakdown estimates & forecasts, 2018-2027

9.2.1.4. End Use Outlook breakdown estimates & forecasts, 2018-2027

9.2.2. Canada Rare Disease Generic Testing Market

9.3. Europe Rare Disease Generic Testing Market Snapshot

9.3.1. U.K. Rare Disease Generic Testing Market

9.3.2. Germany Rare Disease Generic Testing Market

9.3.3. France Rare Disease Generic Testing Market

9.3.4. Spain Rare Disease Generic Testing Market

9.3.5. Italy Rare Disease Generic Testing Market

9.3.6. Rest of Europe Rare Disease Generic Testing Market

9.4. Asia-Pacific Rare Disease Generic Testing Market Snapshot

9.4.1. China Rare Disease Generic Testing Market

9.4.2. India Rare Disease Generic Testing Market

9.4.3. Japan Rare Disease Generic Testing Market

9.4.4. Australia Rare Disease Generic Testing Market

9.4.5. South Korea Rare Disease Generic Testing Market

9.4.6. Rest of Asia Pacific Rare Disease Generic Testing Market

9.5. Latin America Rare Disease Generic Testing Market Snapshot

9.5.1. Brazil Rare Disease Generic Testing Market

9.5.2. Mexico Rare Disease Generic Testing Market

9.6. Rest of The World Rare Disease Generic Testing Market

Chapter 10. Competitive Intelligence

10.1. Top Market Strategies

10.2. Company Profiles

10.2.1. Quest Diagnostics Inc

10.2.1.1. Key Information

10.2.1.2. Overview

10.2.1.3. Financial (Subject to Data Availability)

10.2.1.4. Product Summary

10.2.1.5. Recent Developments

10.2.2. Centogene N.V.

10.2.3. Invitae Corporation

10.2.4. 3billion, Inc.

10.2.5. Arup Laboratories

10.2.6. Eurofins Scientific

10.2.7. Strand Life Sciences

10.2.8. Ambry Genetics

10.2.9. Perkin Elmer, Inc.

10.2.10. Macrogen, Inc.

Chapter 11. Research Process

11.1. Research Process

11.1.1. Data Mining

11.1.2. Analysis

11.1.3. Market Estimation

11.1.4. Validation

11.1.5. Publishing

11.2. Research Attributes

11.3. Research Assumption

List of Tables

TABLE 1. Global Rare Disease Generic Testing Market , report scope

TABLE 2. Global Rare Disease Generic Testing Market estimates & forecasts by Region 2018-2027 (USD Billion)

TABLE 3. Global Rare Disease Generic Testing Market estimates & forecasts by Disease Type 2018-2027 (USD Billion)

TABLE 4. Global Rare Disease Generic Testing Market estimates & forecasts by Technology Outlook 2018-2027 (USD Billion)

TABLE 5. Global Rare Disease Generic Testing Market estimates & forecasts by Speciality Outlook 2018-2027 (USD Billion)

TABLE 6. Global Rare Disease Generic Testing Market estimates & forecasts by End Use Outlook 2018-2027 (USD Billion)

TABLE 7. Global Rare Disease Generic Testing Market by segment, estimates & forecasts, 2018-2027 (USD Billion)

TABLE 8. Global Rare Disease Generic Testing Market by region, estimates & forecasts, 2018-2027 (USD Billion)

TABLE 9. Global Rare Disease Generic Testing Market by segment, estimates & forecasts, 2018-2027 (USD Billion)

TABLE 10. Global Rare Disease Generic Testing Market by region, estimates & forecasts, 2018-2027 (USD Billion)

TABLE 11. Global Rare Disease Generic Testing Market by segment, estimates & forecasts, 2018-2027 (USD Billion)

TABLE 12. Global Rare Disease Generic Testing Market by region, estimates & forecasts, 2018-2027 (USD Billion)

TABLE 13. Global Rare Disease Generic Testing Market by segment, estimates & forecasts, 2018-2027 (USD Billion)

TABLE 14. Global Rare Disease Generic Testing Market by region, estimates & forecasts, 2018-2027 (USD Billion)

TABLE 15. Global Rare Disease Generic Testing Market by segment, estimates & forecasts, 2018-2027 (USD Billion)

TABLE 16. Global Rare Disease Generic Testing Market by region, estimates & forecasts, 2018-2027 (USD Billion)

TABLE 17. U.S. Rare Disease Generic Testing Market estimates & forecasts, 2018-2027 (USD Billion)

TABLE 18. U.S. Rare Disease Generic Testing Market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 19. U.S. Rare Disease Generic Testing Market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 20. Canada Rare Disease Generic Testing Market estimates & forecasts, 2018-2027 (USD Billion)

TABLE 21. Canada Rare Disease Generic Testing Market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 22. Canada Rare Disease Generic Testing Market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 23. UK Rare Disease Generic Testing Market estimates & forecasts, 2018-2027 (USD Billion)

TABLE 24. UK Rare Disease Generic Testing Market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 25. UK Rare Disease Generic Testing Market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 26. Germany Rare Disease Generic Testing Market estimates & forecasts, 2018-2027 (USD Billion)

TABLE 27. Germany Rare Disease Generic Testing Market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 28. Germany Rare Disease Generic Testing Market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 29. RoE Rare Disease Generic Testing Market estimates & forecasts, 2018-2027 (USD Billion)

TABLE 30. RoE Rare Disease Generic Testing Market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 31. RoE Rare Disease Generic Testing Market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 32. China Rare Disease Generic Testing Market estimates & forecasts, 2018-2027 (USD Billion)

TABLE 33. China Rare Disease Generic Testing Market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 34. China Rare Disease Generic Testing Market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 35. India Rare Disease Generic Testing Market estimates & forecasts, 2018-2027 (USD Billion)

TABLE 36. India Rare Disease Generic Testing Market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 37. India Rare Disease Generic Testing Market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 38. Japan Rare Disease Generic Testing Market estimates & forecasts, 2018-2027 (USD Billion)

TABLE 39. Japan Rare Disease Generic Testing Market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 40. Japan Rare Disease Generic Testing Market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 41. RoAPAC Rare Disease Generic Testing Market estimates & forecasts, 2018-2027 (USD Billion)

TABLE 42. RoAPAC Rare Disease Generic Testing Market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 43. RoAPAC Rare Disease Generic Testing Market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 44. Brazil Rare Disease Generic Testing Market estimates & forecasts, 2018-2027 (USD Billion)

TABLE 45. Brazil Rare Disease Generic Testing Market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 46. Brazil Rare Disease Generic Testing Market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 47. Mexico Rare Disease Generic Testing Market estimates & forecasts, 2018-2027 (USD Billion)

TABLE 48. Mexico Rare Disease Generic Testing Market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 49. Mexico Rare Disease Generic Testing Market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 50. RoLA Rare Disease Generic Testing Market estimates & forecasts, 2018-2027 (USD Billion)

TABLE 51. RoLA Rare Disease Generic Testing Market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 52. RoLA Rare Disease Generic Testing Market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 53. Row Rare Disease Generic Testing Market estimates & forecasts, 2018-2027 (USD Billion)

TABLE 54. Row Rare Disease Generic Testing Market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 55. Row Rare Disease Generic Testing Market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 56. List of secondary sources, used in the study of global Rare Disease Generic Testing Market

TABLE 57. List of primary sources, used in the study of global Rare Disease Generic Testing Market

TABLE 58. Years considered for the study

TABLE 59. Exchange rates considered

Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Contact Us

Drop Us an email at

Similar Reports

Client Testimonials

Maria

David

Sara